{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:00:19Z","timestamp":1791414019825,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejogrb.2017.04.042","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T14:20:53Z","timestamp":1493389253000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Endometrial changes during ulipristal acetate use: A systematic review"],"prefix":"10.1016","volume":"214","author":[{"given":"Inge","family":"De Milliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Van Hattum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.F.","family":"Ket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.F.","family":"Huirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.K.","family":"Hehenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10\u201313","key":"10.1016\/j.ejogrb.2017.04.042_bib0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-128X(03)00130-2","article-title":"Pharmacologic properties of CDB(VA)-2914","volume":"68","author":"Gainer","year":"2003","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.04.042_bib0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2003.12.004","article-title":"In vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone","volume":"88","author":"Attardi","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.04.042_bib0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2017.04.042_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pa.36.040196.000403","article-title":"Antiprogestins: mechanism of action and contraceptive potential","volume":"36","author":"Spitz","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.04.042_bib0160","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic\u2013pituitary\u2013ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.04.042_bib0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.ejogrb.2017.04.042_bib0175","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejogrb.2017.04.042_bib0180","series-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.04.042_bib0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0190","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"85","author":"Brache","year":"2012","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.04.042_bib0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.contraception.2014.08.006","article-title":"A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception","volume":"90","author":"Huang","year":"2014","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.04.042_bib0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2015.12.015","article-title":"A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30mg ulipristal acetate","volume":"93","author":"Jesam","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.04.042_bib0205","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.fertnstert.2008.12.057","article-title":"Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914","volume":"93","author":"Stratton","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0210","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2017.04.042_bib0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jmig.2016.01.010","article-title":"Hysteroscopic patterns in women on treatment with ulipristal acetate 5mg\/day: a preliminary study","volume":"23","author":"Bettocchi","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2017.04.042_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.04.042_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.ejogrb.2017.04.042_bib0230","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14728222.2016.1180368","article-title":"Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies","volume":"20","author":"Wagenfeld","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.04.042_bib0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09513590.2015.1106471","article-title":"Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis","volume":"32","author":"Kalampokas","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2017.04.042_bib0240","first-page":"315","article-title":"Mechanism of action of ulipristal acetate for emergency contraception: a systematic review","volume":"6","author":"Rosato","year":"2015","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ejogrb.2017.04.042_bib0245","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.contraception.2012.08.021","article-title":"Emergency contraception \u2013 mechanisms of action","volume":"87","author":"Gemzell-Danielsson","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2017.04.042_bib0250","first-page":"285","article-title":"Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids","volume":"8","author":"Biglia","year":"2014","journal-title":"Drug Des Dev Ther"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517302154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:38:40Z","timestamp":1759556320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517302154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":25,"alternative-id":["S0301211517302154"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.04.042","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrial changes during ulipristal acetate use: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}